|
References:
• Fujiwara Y et al. Brief screening
tool for mild cognitive impairment in older Japanese: Validation of the
Japanese
version of the Montreal Cognitive Assessment. Geriatr Gerontol Int.
2010;10:225-232.
• Park J et al. The validity of the
Korean-Montreal Cognitive Assessment (K-MoCA) as a screening test for both
MCI and VCI. Conference abstract presented at the 20th Annual
Rotman Research Institute Conference,
The frontal lobes, Toronto, Canada, March 22-26, 2010.
• Guo Qi-Hao et al. Application study
of quick cognitive screening test in identifying mild cognitive
impairment.
Neuroscience Bulletin Feb. 2010, 26 (1): 47:54.
• Manuel Montero-Odasso, Susan W. Muir.
Simplifying detection of mild cognitive impairment subtypes.
Journal of the American Geriatrics Society, May 2010-Vol. 58, no. 5.
• Cameron J. et al. Does cognitive
impairment predict poor self-care in patients with heart failure?
European Journal
of Hearth failure (2010) 12, 508-515.
• Walter Wittich, Natalie Phillips, Ziad
Nasreddine, Howard Chertkow. Sensitivity and specificity of the
Montreal
Cognitive Assessment modified for individuals who are visually impaired. Journal of
Visual Impairment & Blindness,
104(6), 360-368, June 2010.
• Sarah H. et al. Pilot study of a
three-step diagnostic pathway for young and old patients with Parkinson's
disease
dementia: screen, test and then diagnose. International Journal of
Geriatric Psychiatry 2010; 25: 258-265.
• Sarah T. Pendlebury et al.
Underestimation of Cognitive Impairment by Mini-Mental State Examination
Versus
the Montreal Cognitive Assessment in Patients with Transient Ischemic
Attack and Stroke. A Population-Based Study.
Stroke Journal of the American Heart Association, 41(6):1290-1293, June
2010.
• Gagnon JF. et al. The Montreal Cognitive Assessment: A Screening
Tool for Mild Cognitive Impairment in REM
Sleep Behavior Disorder. Movement Disorders 2010, online e-pub
before paper.
• Videnovic A., et al. The Montreal Cognitive Assessment as a
screening tool for cognitive dysfunction in Huntington's
disease. Movement Disorders, 2010: 25 (3): 401-4.
• Olson R., Parkinson M., McKenzie M. Selection Bias Introduced by
Neuropsychological Assessments. Canadian
Journal of Neurological Sciences, 2010; 37: 264-268.
• Lessig S. et al. Usefulness of Two Brief Cognitive Screening
Measures in Huntington's Disease. Poster.
Neurotherapeutics, Vol. 7, No 1, 2010, Page 139.
• Hoops S et al. Validity of the MoCA and MMSE in the detection of
MCI and dementia in
Parkinson disease. Neurology 2009 Nov. 24 ; 73(21):1738-1745.
• Copersino ML et al. Rapid cognitive screening of patients with
substance use disorders.
Experimental and Clinical Psychopharmacology 17(5): 337-344, 2009.
• Duro D et al. Validation studies of the Portuguese experimental
version of the
Montreal Cognitive Assessment (MoCA): confirmatory factor analysis. J. Neurol. 2009, Nov. 25 (epub
ahead of print).
• Rolf Sebaldt, William Dalziel, Fadi
Massoud, André Tanguay, Rick Ward, Lehana Thabane,
Peter Melnyk, Pierre-Alexandre Landry, Benedicte Lescrauwaet. Detection of
Cognitive Impairment and Dementia
Using the Animal Fluency Test: The Decide Study, The Canadian Journal of
Neurological Sciences, Volume 36,
issue 5, Sept. 2009, page 599.
• Ging-Yuek R. Hsiung et al. A Pilot
Study on Computerized Cognitive Training in Mild Cognitive Impairment.
5th Canadian Conference on Dementia in Toronto, Oct. 1-3 2009. The
Canadian Journal of Geriatrics, Volume 12,
issue 3, September 2009, page 124.
• A. Garcia et al. Apathy in
Dementia: Are we detecting it? 5th Canadian Conference on Dementia in
Toronto,
Oct. 1-3 2009. The Canadian Journal of Geriatrics, Volume 12, issue
3, September 2009, page 121.
• Lisa Sweet, phd et al. The Montréal Cognitive Assessment (MoCA) in
Geriatric Rehabilitation: Psychometric
Properties and Association with Rehabilitation Outcomes.
5th Canadian Conference on Dementia in Toronto,
Oct. 1-3 2009. The Canadian Journal of Geriatrics, Volume
12, issue 3, September 2009, page 113.
• Bejamin Lam et al. Validation of the Montreal Cognitive Assessment
against Detailed Neuropsychological Measures.
5th Canadian Conference on Dementia in Toronto, Oct. 1-3 2009. The
Canadian Journal of Geriatrics, Volume 12,
issue 3, September 2009, page 138.
• Hemrungrojn S et al. The cognitive domains from
Thai-Montreal cognitive assessment test to discriminate between
amnestic MCI and mild AD from normal aging. Presented at the International Psychogeriatric
Association Conference,
September 2009, Montreal, Quebec, Canada.
• Tangwongchai S et al. The Validity of Thai version of The Montreal
Cognitive Assessment (MoCA-T), Presented at the
International Psychogeriatric Association Conference, September 2009, Montreal, Quebec, Canada.
• Janneke Thissen et al. Validity of the Montreal Cognitive Assessment
Dutch Version (MoCA-D), Presented at the
International Psychogeriatric Association Conference, September 2009, Montreal, Quebec, Canada.
• Adrian Wong et al. The
Validity, Reliability and Clinical Utility of the Hong Kong Montreal
Cognitive Assessment
(HK-MoCA) in Patients with Cerebral Small Vessel Disease, Dement Geriatr
Cogn Disord Aug. 2009;28:81-87.
• Olson R, Iverson G,
Parkinson M, Carolan H, Ellwood A, McKenzie M. Investigation of cognitive screening measures in
patients with brain tumors: diagnostic accuracy & correlation with
quality of life. 2009 American Society of Clinical
Oncology Annual Meeting. Orlando, Florida. May 29-June 2,
2009. Abstract ID: e13000.
• Olson R, Iverson G, Parkinson M, Carolan H,
Ellwood A-L, McKenzie M. Comparison of the Mini Mental State
Examination (MMSE) and the Montreal Cognitive Assessment (MoCA) to a
Comprehensive Neuropsychological
Assessment in Patients with Brain Tumors. 11th World Congress of
Psycho-Oncology. Vienna, Austria.
June 21-25, 2009. Abstract P3.7.17
• Olson R, Ellwood A-L, Parkinson M, Carolan H,
Ferguson K, Iverson G, McKenzie M.
Comparison of Two Cognitive Screening Measures, the Mini Mental State Examination
(MMSE) and the
Montreal Cognitive Assessment (MoCA), in Patients with Brain Tumors.
Canadian Association of Psychosocial Oncology, 2009 Conference. Vancouver,
British Columbia. April 1-4, 2009. Abstract ID:
P245.
• JL Richard, LL Boyle,
MS Ismail, X Tu. Use of the MOCA in Patients Presenting to a Memory Disorders Clinic.
Am J Geriatr Psychiatry 2009; 17:A112.
• Rahman, Tomader Taha Abdel;El Gaafary, Maha
Mohamed. Montreal Cognitive Assessment Arabic version:
Reliability and validity prevalence of mild cognitive impairment among elderly attending geriatric clubs in Cairo.
Geriatrics and Gerontology International, Vol. 9, Number 1, March 2009,
pp. 54-61 (8).
• Irak-Dersu I, Bond C, Evans M, Grigorian P,
Spencer H. Effect of dilating drops on cognitive function.
Presented at
35th annual North American Neuro-ophthalmology meeting, February 24,
2009, Lake Tahoe, Nevada.
• Irak-Dersu I, Bond C, Evans M, Grigorian P,
Spencer H. The Effect of Mydriatic Eye Drops on Cognitive Function
in
Claucoma Patients. Presented at 19th annual American Glaucoma
Society meeting, March 6, 2009, San Diego, CA.
• Sarra et al. Montreal Cognitive
Assessment Performance in Patients with Parkinson's Disease with “Normal”
Global
Cognition According to Mini-Mental State Examination Score. J Am Geriatr
Soc Vol 57, Num 2, February 2009,
pp. 304-308(5).
• Corey-Bloom J. et al. A Comparison of Two
Brief Cognitive Instruments in Huntington Disease (HD). Poster
presentation. Neurotherapeutics, Vol 6, Issue 1, Page 206 (January
2009).
• Wong A. et al. The Validity, Reliability and Utility of the Cantonese
Montreal CognitiveAssessment (MoCA) in Chinese
Patients with Confluent White Matter Lesions. Hong Kong Med J Vol 14 No 6
# Supplement 6 #, December 2008.
• Luis CA, et al. Cross validation of the
Montreal Cognitive Assessment in community dwelling older adults residing in
the Southeastern US. International Journal of Geriatric Psychiatry, Online issue, October 21st, 2008,
published
2009;24: 197-201.
• Lessig S. et al. Examination of the Montreal Cognitive Assessment (MoCA)
and MMSE in Parkinson's disease (PD).
Abstract T-82. Presented at American Neurological Association Meeting,
Salt Lake City, Utah, September 24th, 2008.
• Joanna Magierska, Radoslaw Magierski, Tomasz Sobow, Iwona Kloszewska.
The Polish adaptation of the Montreal
Cognitive Assessment (MoCA) and preliminary results of its clinical utility in the screening for cognitive impairment.
Poster presented at the ICAD Conference, 2008.
• K. Waspe, G. Vorobeychik, N. Beauregard Evaluation of Modified Montreal
Cognitive assessment in multiple
sclerosis: a pilot study. Multiple Sclerosis, 2008; 14(supp 1) p. S29. Presented at ECTRIMS meeting, Montreal,
Sept. 2008.
• Bertolucci PH et al. Brazilian Portuguese version for the Montreal
Cognitive Assessment (MoCA) and the preliminary
results. Presented at Alzheimer's Association International Conference on
Alzheimer's Disease. Alzheimer's and
Dementia Vol 4, Issue 4, Supplement 1, July 2008, Page T686.
• Song S et al. Executive impairment and
MoCA performance in mild cognitive impairment and Alzheimer's disease.
Presented at the International Neuropsychological Society Annual Meeting. Buenos Aires, Argentina.
July 2-5 2008, p 258.
• Jun-Young Lee et al. Brief Screening for Mild Cognitive Impairment in
Elderly Outpatient
Clinic: Validation of the Korean Version of the Montreal Cognitive Assessment. 2008;
J Geriatr Psychiatry Neurol June 2008, 21;2:104-110.
• Boulanger JM et al. A prospective cognitive evaluation in post stroke/TIA
patients using the
Montreal Cognitive Assessment test (MoCA) . Presented at Nice, France. European Stroke Conference, May 2008.
• Johns, EK et al. The effect of education on performance on the Montreal
Cognitive Assessment
(MoCA):
Normative data from the community. The Canadian Journal of Geriatrics, 11, 32-73. [Poster presented at the
28th annual meeting of the Canadian Geriatrics Society, Montreal, QC, April 2008.
• Ratchford TL, et al. Normative Data for the Montreal Cognitive
Assessment (MoCA) in Young Adults. P05.128.
Presented at the American Academy of Neurology Meeting. April 2008. Neurology 70 March 11, 2008 (Suppl 1) A283.
• Gill DJ et al. The montreal cognitive assessment as a screening tool for
cognitive impairment in Parkinson's
disease. Mov Disorders, Volume 23, Issue
7, 2008.
• Ponrathi Athilingam. The Montreal Cognitive Assessment (MoCA): An
appropriate tool to assess subtle cognitive
changes in people with heart failure? Section: "Innovations in Nursing Practice with Older Adults". Presented at the
ENRS 20th scientific conference. Philadelphia, March 27 th, 2008.
• Olson RA et al. Feasibility study of the Montreal Cognitive Assessment (MoCA)
in patients with brain metastases.
0941-4355 (Print) 1433-7339 (Online) Supportive Care in Cancer.
Wednesday, March 12, 2008, 16:1273-1278
• Nestor SM et al. The Montreal Cognitive Assessment: a retrospective
pilot study measuring longitudinal cognitive
change in people with mild cognitive impairment. Presented at the
Annual
Meeting of the Canadian Geriatrics
Society, Montreal Canada, Canadian J of Geriatrics Vol 11, Issue 1,
March
2008, p63.
•
Koski L. et al. Measuring Cognition in a Geriatric Outpatient Clinic:
Rasch Analysis of the Montreal Cognitive
Assessment. Journal of Geriatric Psychiatry and Neurology, Vol 22, No 3,
Sept. 2009, Page 151-160.
• Smith M, et al. Case finding of people
with cognitive impairment using screening clinics during Alzheimer
awareness month. Presented at the Annual Meeting of the Canadian Geriatrics
Society, Montreal Canada,
Canadian J of Geriatrics Vol 11, Issue 1, March 2008, p37.
• Johns, EK et al. The Montreal Cognitive Assessment: Normative data in
the community. Journal of the International
Neuropsychological Society, 14(Suppl. 1), i-292. [Poster presented at the
36th annual meeting of the International
Neuropsychological Society, Waikoloa, Hawaii, February 2008].
• Zadikoff C et al. A comparison of the mini mental state exam to the
Montreal cognitive assessment in identifying
cognitive deficits in Parkinson's disease. Mov Disord. 2008 Jan
30;23(2):297-9.
• Wen HB et al. The application of Montreal cognitive assessment in urban
Chinese residents of Beijing. Zhonghua Nei
Ke Za Zhi. 2008 Jan;47(1):36-9. Chinese.
• Tobinick et al. Rapid cognitive
improvement in Alzheimer’s disease following perispinal etanercept
administration.
J of Neuroinflammation January 2008, 5:2 (e-publication, paper
publication to come).
• Shiroky et al. Can you have dementia with an MMSE score of 30. Am J of Alzeimers Dis Other Demen
Oct-Nov 2007;22:5;406-415.
• Chertkow H, Nasreddine Z, Joanette Y, Drolet V, Kirk J, Massoud F,
Belleville S, Bergman H. Mild
cognitive impairment and cognitive impairment, no dementia: Part A,
concept and diagnosis
Alzheimer's & Dementia: The Journal of the Alzheimer's Association
October 2007
(Vol. 3, Issue 4, Pages 266-282).
• Howe E. Initial screening of patients for Alzheimer's disease and
minimal cognitive impairment.
Psychiatry. Vol 4(7) Jul 2007, 24-27.
• Holsinger et al. Does this patient have
dementia? JAMA, June 6, 2007-Vol 297, No 21;2391-2404.
• Smith T et al. The Montreal Cognitive Assessment: validity and utility
in a memory clinic setting. Can J
Psychiatry. 2007 May; 52(5):329-32.
• Martinić Popović I. et al. Mild cognitive impairment in symptomatic and
asymptomatic cerebrovascular disease
Journal of the Neurological Sciences Volume 257, Issues 1-2, 15 June
2007, Pages 185-193.
• Hachinski et al. National Institute of Neurological Disorders and
Stroke-Canadian Stroke Network vascular cognitive
impairment harmonization standards. Stroke. 2006, Sep;37(9):2220-41. Epub
2006 Aug 17.
• Gauthier et al. Mild
cognitive impairment. Lancet. 2006 Apr 15;367(9518):1262-70. Review.
• J. Reban. Montrealsky kognitivni test /MoCA/: přínos k diagnostice
predemencí, Česká Geriatrická Revue 2006
(4):224-229.
• Martinic-Popovic I. et al. Early detection of mild cognitive impairment
in patients with cerebrovascular disease.
Acta Clin Croat 2006;45:77-85.
• Allan L et al. Mild Cognitive Impairment: An Opportunity to Identify
Patients at High Risk for Progression to
Alzheimer's Disease. Clin Ther
2006;28:991-1001.
• Nasreddine
ZS, Phillips NA, Bédirian V, Charbonneau S, Whitehead V, Collin I, Cummings JL, Chertkow
H.
The Montreal Cognitive Assessment (MoCA): A Brief
Screening Tool For Mild Cognitive Impairment. J Am Geriatr
Soc 53:695–699,
2005.
• Nasreddine ZS, Chertkow H, Phillips N, Whitehead V, Collin I,
Cummings JL. The Montreal Cognitive
Assessment (MoCA): a Brief Cognitive
Screening Tool for Detection of Mild Cognitive Impairment. Neurology Vol
62
No 7 S(5) April 2004 A132. Presented at the American Academy of
Neurology Meeting, San Francisco, May 2004.
• Nasreddine
ZS, Chertkow H, Phillips N, Whitehead V, Bergman H, Collin I, Cummings JL, Hébert L.
The Montreal Cognitive Assessment (MoCA): a Brief
Cognitive Screening Tool for Detection of Mild Cognitive
Impairment. Presented at the 8th International Montreal/Springfield Symposium on
Advances in Alzheimer Therapy.
http://www.siumed.edu/cme/AlzBrochure04.pdf
p. 90, April 14-17, 2004.
• Nasreddine ZS, Collin I, Chertkow H, Phillips N, Bergman H,
Whitehead V. Sensitivity and Specificity of The Montreal
Cognitive
Assessment (MoCA) for Detection of Mild Cognitive Deficits. Can J Neurol
Sci Volume 30, Number 2
Supplement 2/May 2003 p 30. Presented at
Canadian Congress of Neurological Sciences Meeting, Québec City,
Québec,
June 2003.
|